Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Mitchell

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.
The Medical Journal of Australia|October 10, 2019
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndromeYoon-Jung Kang, James Killen, Michael Caruana, et al.
Cancer Research|February 3, 2006
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriersGillian Mitchell, Antonis C Antoniou, Ruth Warren, et al.
Plos One|February 2, 2013
High levels of genomic aberrations in serous ovarian cancers are associated with better survivalLars O Baumbusch, Åslaug Helland, Yun Wang, et al.
European Journal of Human Genetics : EJHG|March 31, 2018
Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family historyBettina Meiser, Veronica F Quinn, Gillian Mitchell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2016
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trialVeronica F Quinn, Bettina Meiser, Judy Kirk, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
Plos Genetics|October 3, 2012
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility allelesElla R Thompson, Maria A Doyle, Georgina L Ryland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcomeZhigang C Wang, Nicolai Juul Birkbak, Aedín C Culhane, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.
The Medical Journal of Australia|October 10, 2019
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndromeYoon-Jung Kang, James Killen, Michael Caruana, et al.
Cancer Research|February 3, 2006
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriersGillian Mitchell, Antonis C Antoniou, Ruth Warren, et al.
Plos One|February 2, 2013
High levels of genomic aberrations in serous ovarian cancers are associated with better survivalLars O Baumbusch, Åslaug Helland, Yun Wang, et al.
European Journal of Human Genetics : EJHG|March 31, 2018
Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family historyBettina Meiser, Veronica F Quinn, Gillian Mitchell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2016
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trialVeronica F Quinn, Bettina Meiser, Judy Kirk, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
Plos Genetics|October 3, 2012
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility allelesElla R Thompson, Maria A Doyle, Georgina L Ryland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcomeZhigang C Wang, Nicolai Juul Birkbak, Aedín C Culhane, et al.
Pageof 12